RCT of senolytic fisetin combined with biofeedback after meniscus repair in development
This is a registered randomized clinical trial protocol testing a combined intervention after arthroscopic meniscus repair: oral senolytic fisetin plus a real-time biofeedback program to restore joint loading and return to activity. The study aims to address meniscus injury recovery and reduce posttraumatic osteoarthritis risk in a population with high prevalence of meniscal procedures.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: May 8, 2025 · Discovered: Sep 16, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- Patients undergoing arthroscopic meniscal repair
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- Austin V Stone
- Published
- May 8, 2025
Sources
Primary source
- Austin V Stone ↗Clinical trial
Source versions
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.